Non-invasive Venous Pressure Estimation
Non-invasive Central Venous Pressure Estimation in Cardiac Intensive Care
1 other identifier
interventional
40
1 country
1
Brief Summary
The non-invasive central venous pressure estimation in adult cardiac intensive care units (CICU) patients study is a single-center, single-arm, investigator-blinded, interventional, intra-participant comparative, feasibility study. This study aims to assess the safety and preliminary accuracy of external jugular venous occlusion pressure measured non-invasively with the venous occlusion pressure monitoring device (CPMX2) in adult CICU patients. As a feasibility study, the primary goal is to gather preliminary data on the feasibility, safety, and effectiveness of the non-invasive CVP estimation method. Although single arm, the study will compare non-invasive CVP measurements with standard invasive CVP measurements taken concurrently. This intra-participant comparative approach is essential to validate the correlation and reliability of the non-invasive method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2025
CompletedFirst Posted
Study publicly available on registry
November 10, 2025
CompletedStudy Start
First participant enrolled
January 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
January 21, 2026
January 1, 2026
10 months
November 6, 2025
January 16, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Mean venous pressure to assess accuracy
Mean CPMX2 external jugular occlusion pressure will be compared to invasive CVP measurement in mmHg
Day 1
Number of adverse events to assess safety
Safety measured by number of adverse events related to or potentially related to the study device and device deficiencies reported during study
Day 1
Number of device deficiencies to assess safety
Safety measured by number of device deficiencies reported during study
Day 1
Secondary Outcomes (1)
Mean Point-of-care ultrasound (POCUS)-derived pressure measurements
Day 1
Study Arms (1)
Adult CICU patients- CPMX2
EXPERIMENTALAdult participants admitted to the CICU will have external jugular venous occlusion pressure measured twice non-invasively with the venous occlusion pressure monitoring device (CPMX2) and twice using standard of care invasive central venous pressure (CVP) measurements. All measurements will be taken concurrently. This is a with-in participant design.
Interventions
Eligibility Criteria
You may qualify if:
- Provision of signed and dated informed consent
- Admitted to the CICU with invasive CVP/RA pressure monitoring placed by standard of care as determined by the treating team before enrollment
- No more than moderate TR as assessed by echocardiogram
You may not qualify if:
- Undergoing positive pressure ventilation (Bipap or invasive mechanical ventilation)
- Non-visible external jugular vein bilaterally (by visual examination or with traditional ultrasound examination)
- History of thrombosis in any of the following vessels bilaterally; external jugular vein, internal jugular vein, brachiocephalic vein or superior vena cava
- Skin lesions, vascular access sites or dressings covering neck and impeding access to the external jugular veins at the level of the muscle belly of the sternocleidomastoid muscle
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- Compremium AGcollaborator
Study Sites (1)
Yale New Haven Hospital CICU
New Haven, Connecticut, 06520, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Elliott Miller, MD, MHS
Yale University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 6, 2025
First Posted
November 10, 2025
Study Start
January 6, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
January 21, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share